ABSTRACT
AIM: Genotyping and phylogenetic analysis of parvovirus B19 isolates isolated on the territories of Northwestern Federal District (NWFD) of Russia. MATERIALS AND METHODS: 61 blood sera and 30 oropharyngeal lavages obtained from patients with maculopapular rash from various territories of NWFD were studied for the presence of parvovirus B 19 DNA (PVB 19). DNA isolation and amplification was carried out by standard techniques. DNA segment including fragment of non-structural gene NS1 and region of structural gene VPI (NS1-VPlu, 994 nucleotides) was sequenced, original sequences ofoligonucleotide primers were selected for this purpose. Phylogenetic analysis was carried out online on the website http://www.phylogeny.fr. Data for tree construction was obtained from GenBank. RESULTS: PVB 19 DNAwas detected in 45% ofsamples. PVB19 genome segment was sequenced in 8 samples. All the PVB 19 isolates belong to a single cluster of 1A genotype. Isolate 57.12 from Komi Republic is similar to ISR-G strain isolated from Israel. CONCLUSION: Phylogenetic analysis showed a high degree of genetic similarity between PVB 19 isolates circulating on the territories of NWFD, their membership in the most widespread genotype in the world. Local and import cases ofparvovirus infection (PVI) were identified. The authors make a conclusion on the necessity to include PVI into the system of rubella and measles control.
Subject(s)
DNA, Viral/genetics , Erythema Infectiosum/genetics , Genotype , Parvovirus B19, Human/genetics , Phylogeny , Sequence Analysis, DNA , Base Sequence , Erythema Infectiosum/epidemiology , Female , Humans , Male , Molecular Sequence Data , Parvovirus B19, Human/isolation & purification , Russia/epidemiologyABSTRACT
A group of volunteers was exposed to action of heating microclimate (ambient temperature 30 +/- 1 degrees C, relative humidity 35 +/- 5%) and other critical occupation factors (physical loading, personal protective equipment). They received simultaneously one of the medicines: placebo, bemethyl (0.5 g), phenibut (0.25 g), obsidan (0.08 g), or phenibut (0.25 g) combined with obsidan (0.08 g). Combined phenibut (0.25 g) with obsidan (0.08 g) were proved to be the most effective method to increase stability of the human body against studying critical occupational factors.
Subject(s)
Adjuvants, Immunologic/pharmacology , Anti-Anxiety Agents/pharmacology , Benzimidazoles/pharmacology , Body Temperature Regulation/drug effects , Hot Temperature , Occupational Health , Propranolol/pharmacology , Tranquilizing Agents/pharmacology , gamma-Aminobutyric Acid/analogs & derivatives , Anti-Anxiety Agents/administration & dosage , Humans , Microclimate , Propranolol/administration & dosage , Tranquilizing Agents/administration & dosage , gamma-Aminobutyric Acid/administration & dosage , gamma-Aminobutyric Acid/pharmacologyABSTRACT
The authors studied the effect of single intake of bymetil (0.5 g) and phenibut (0.25 g) on the thermal state, gas-energy exchange, blood oxygenation, working capacity, and the subjective status of man in intensive physical exertion in isolating means of individual protection. The drugs under study increased thermal resistance, promoted normal supply of the organism with oxygen, and provided the maintenance of man's high working capacity under conditions which lead to his overheating. The best protective effects was produced in this case with phenibut.